ABL Medical Inc., a subsidiary of IlluminOss Medical Inc, has introduced a novel system in the United States utilizing blue light through an extended fiber-optic catheter to solidify light-curing liquid within orthopedic implants resembling balloons. Recent findings from ABL Medical suggest that their fiber-optic technology employing blue light can be repurposed for antimicrobial applications.

The data presented indicates that specific frequencies of antimicrobial blue light delivered through fiber-optic technology can be integrated into various medical devices such as catheters and endotracheal tubes. Laboratory studies have long demonstrated the antimicrobial effects of certain frequencies of visible blue light. However, different bacterial species respond diversely to light frequencies, with some being more or less susceptible. Blue light deactivates pathogens by stimulating their oxygen-carrying molecules, prompting them to produce unstable oxygen compounds that disrupt essential cell structures, including DNA bonds.

This damage occurs swiftly and extensively, preventing microorganisms from defending themselves or developing resistance, unlike antibiotics. The ABL system in development employs a patented light source and optical delivery system that emits multiple frequencies of light through a single fiber. Unlike existing systems that emit light from a single point source, the ABL multifrequency system evenly distributes blue light throughout a catheter or similar medical instrument to achieve antimicrobial effects. This innovative technology has the potential to safely deliver blue light to anatomical sites previously inaccessible for such treatment.

Source: prnewswire.com

 

 

Report Abuse